Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind placebo-controlled multicenter trial of ramelteon tablets for sleep-onset insomnia in Chinese adults
CTR20252900Phase 3Active
- Sponsor
- Sichuan Kered Pharmaceutical
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ramelteon in chronic insomnia, Insomnia, sponsored by Sichuan Kered Pharmaceutical. Started Sep 2025; status: active.
02
Drugs
ramelteon
03
Conditions
chronic insomniaInsomnia
Beyond the preview
Go deeper on CTR20252900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252900.